Our in vitro experiments demonstrated that IL-2 modulated expression of CD25 on B cells after activation /expansion (A/E) before adoptive transfer; enhanced CXCR4 expression on B cells; augmented CXCL12 production by 4T1 tumor cells, and increased production of perforin by B cells. This evidence concerns the gene CXCL12 and neoplasm.